{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:12:53Z","timestamp":1768810373439,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Liaoning Province","award":["20170540254"],"award-info":[{"award-number":["20170540254"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Poorly differentiated neuroendocrine carcinoma of the breast is a rare cancer with poor prognosis. There is no standard treatment for the disease. Neoadjuvant therapies and surgery are considered to be the main treatment when the tumor diameter is greater than 5.0\u200acm. Neoadjuvant therapies include chemotherapy and endocrine therapy. However, the effect of neoadjuvant endocrine therapy is not clear in the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>In August 2014, a 28-year-old premenopausal woman noted a mass that was approximately 3.0\u200acm\u22172.0\u200acm in size on her right breast with pain. Subsequently, the mass has been always increasing significantly. In August 2015, the mass was approximately 7.0\u200acm\u22175.0\u200acm in size, accompanied by pain, no nipple retraction and discharge, no orange peel-like skin changes, and no dimples. In addition, she had no salient past history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Histopathological examinations by a biopsy with a thick needle (hollow needle) and surgical resection confirmed poorly differentiated neuroendocrine carcinoma of the right breast.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>First and remarkably, she underwent 3 months of neoadjuvant endocrine therapy (goserelin once every 28 days, and letrozole 10\u200amg every day). Then, she underwent surgery - stage I breast reconstruction by using prosthesis. Adjuvant endocrine therapy has been used since the operation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>According to response evaluation criteria in solid tumors 1.1, the tumor was shrunk by 78.87% after neoadjuvant endocrine therapy. No salient complications were observed. We have followed her for 48 months, and there are no signs of recurrence and metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Poorly differentiated neuroendocrine carcinoma of the breast is rare and has a poor prognosis. Currently, there is no standard treatment for this disease. Studies show estrogen receptor and progesterone receptor of neuroendocrine carcinoma of the breast are often highly expressed. In the case, it can be observed that estrogen receptor and progesterone receptor are highly expressed. Therefore, neoadjuvant endocrine therapy may be considered in neuroendocrine carcinoma of the breast when the mass is large and the patient refuses neoadjuvant chemotherapy. We hope to provide an attractive evidence for neoadjuvant endocrine therapy of neuroendocrine carcinoma of the breast. However, more cases are still being needed for research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022652","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T01:05:38Z","timestamp":1603501538000},"page":"e22652","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast"],"prefix":"10.1097","volume":"99","author":[{"given":"Yonglin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoting","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaozhen","family":"Ren","sequence":"additional","affiliation":[{"name":"The sixth people's hospital of Dalian, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qimin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushuang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jierong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhai","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Breast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.21037\/jgo.2017.07.02","article-title":"Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome","volume":"8","author":"Serracant Barrera","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1590\/2359-3997000000139","article-title":"Pituitary metastasis of lung neuroendocrine carcinoma: case report and literature review","volume":"59","author":"Siqueira","year":"2015","journal-title":"Arch Endocrinol Metab"},{"key":"R3-20230916","first-page":"1","article-title":"Small-cell neuroendocrine cancer of the prostate: an atypical presentation of a common disease","volume":"2016","author":"Alves","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R4-20230916","first-page":"4093","article-title":"Non-small cell neuroendocrine carcinoma of the ovary in a BRCA2-germline mutation carrier: a case report and brief review of the literature","volume":"15","author":"Herold","year":"2018","journal-title":"Oncol Lett"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00000478-197712000-00001","article-title":"Primary carcinoid tumor of the breast: a report of eight patients","volume":"1","author":"Cubilla","year":"1977","journal-title":"Am Surg Pathol"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2407-14-147","article-title":"Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"R7-20230916","first-page":"887","article-title":"Management of neuroendocrine carcinomas of the breast: a rare entity","volume":"2","author":"Yildirim","year":"2011","journal-title":"Oncol Lett"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5732\/cjc.011.10370","article-title":"Solid neuroendocrine breast carcinoma: mammographic and sonographic features in thirteen cases","volume":"31","author":"Wu","year":"2012","journal-title":"Chin J Cancer"},{"key":"R9-20230916","first-page":"7915806","article-title":"Primary neuroendocrine breast carcinoma in a 13-year-old girl: ultrasonography and pathology findings","volume":"2017","author":"Tchaou","year":"2017","journal-title":"Case Rep Radiol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2147\/OTT.S60782","article-title":"Primary small-cell neuroendocrine carcinoma of the male breast: a rare case report with review of the literature","volume":"7","author":"Jiang","year":"2014","journal-title":"Onco Targets Ther"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1470-2045(11)70373-4","article-title":"Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial","volume":"13","author":"Norikazu","year":"2012","journal-title":"Lancet Oncol"},{"key":"R12-20230916","first-page":"398","article-title":"Pathology and genetics of tumours of the breast and female genital organs","volume":"78","author":"Tavassoli","year":"2003","journal-title":"Int Agency Res Cancer"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.4837","article-title":"The genetic landscape of breast carcinomas with neuroendocrine differentiation","volume":"241","author":"Marchi\u00f2","year":"2017","journal-title":"J Pathol"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00000478-200009000-00006","article-title":"Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients","volume":"24","author":"Shin","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2559.2002.01327.x","article-title":"Is detection of endocrine cells in breast adenocarcinoma of diagnostic and clinical significance?","volume":"40","author":"Sapino","year":"2002","journal-title":"Histopathology"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/modpathol.3880387","article-title":"Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women","volume":"14","author":"Sapino","year":"2001","journal-title":"Mod Pathol"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s13193-014-0370-z","article-title":"Primary neuroendocrine carcinoma of breast","volume":"6","author":"Banu","year":"2015","journal-title":"Indian J Surg Oncol"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1002\/cncr.25352","article-title":"Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma","volume":"116","author":"Wei","year":"2010","journal-title":"Cancer"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40880-017-0211-x","article-title":"Neuroendocrine carcinoma of the breast: a review of 126 cases in China","volume":"36","author":"Li","year":"2017","journal-title":"Chin J Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:53:33Z","timestamp":1694836413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022652"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":20,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022652","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}